SNOA Stock: Exploring Sonoma Pharmaceuticals Inc.’s Growth

Sonoma Pharmaceuticals Inc. (SNOA) has a current stock price of $0.19. During the previous trading session, the stock witnessed a notable rise, reaching a high of $0.192 after opening at $0.16. The stock’s low for the day was $0.16, and it eventually closed at $0.16.

Sonoma Pharmaceuticals Inc.’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $2.68 on 01/25/23, and the lowest price during the same period was recorded at $0.12 on 11/10/23.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


52-week price history of SNOA Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Sonoma Pharmaceuticals Inc.’s current trading price is -92.85% away from its 52-week high, while its distance from the 52-week low is 65.40%. The stock’s price range during this period has fluctuated between $0.12 and $2.68. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.54 million for the day, which was evidently higher than the average daily volume of 0.19 million over the last three months.

Financial Performance and Market Capitalization

Sonoma Pharmaceuticals Inc. (SNOA) has experienced a quarterly decline of -78.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.62M and boasts a workforce of 171 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7795, with a change in price of -0.8883. Similarly, Sonoma Pharmaceuticals Inc. recorded 138,691 in trading volume during the last 100 days, posting a change of -82.25%.

SNOA Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for SNOA stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.02.

SNOA Stock Stochastic Average

The raw stochastic average for Sonoma Pharmaceuticals Inc. over the last 50 days is presently at 8.38%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 17.15%. Further, the company’s Stochastic %K and %D values for the last 20 days were 11.02% and 8.63%, respectively.

SNOA Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -82.88% this year. Over the last six months, there has been a stronger performance of -80.44%. The price of SNOA leaped by -68.58% during the last 30 days period. For the last 5-days stocks have improved 22.41%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts